NVS Jan 2024 87.500 put
- Zacks
FDA Accepts Merck (MRK) sNDA for Welireg in Renal Cell Carcinoma
The FDA filing is supported by data from a late-stage study that shows that Merck's (MRK) Welireg achieved statistically significant and clinically meaningful improvement in progression-free survival.
- Zacks
Novartis' (NVS) Shareholders Approve Sandoz Separation
Novartis' (NVS) shareholders vote in favor of the 100% spin-off of Sandoz into a new publicly traded standalone company.
- GlobeNewswire
Sandoz receives positive CHMP opinion for breast and gastric cancer biosimilar trastuzumab
Positive CHMP opinion based on comprehensive package of analytical, pre-clinical and clinical dataBreast and gastric cancers are among most common types of cancer, accounting together for nearly half a million new cases every year in Europe alone1,2Sandoz is committed to accelerating access to potentially life-changing treatments and continues to strengthen its oncology and supportive care portfolioBasel, September 18, 2023 — Sandoz, a global leader in generic and biosimilar medicines, today ann
